FKBP51 inhibition by SAFit, indeed, sensitized melanoma cells to doxorubicin cytotoxicity, while ectopic expression of FKBP51 reduced the cooperative effect between doxorubicin and SAFit in accordance with the target selectivity of the small molecule. This evidence concerns the gene FKBP5 and melanoma.